140 related articles for article (PubMed ID: 29445446)
1. Down-regulation of miR-210-3p encourages chemotherapy resistance of renal cell carcinoma via modulating ABCC1.
Li S; Yang J; Wang J; Gao W; Ding Y; Ding Y; Jia Z
Cell Biosci; 2018; 8():9. PubMed ID: 29445446
[TBL] [Abstract][Full Text] [Related]
2. miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma.
Long QZ; Du YF; Liu XG; Li X; He DL
Tumour Biol; 2015 Sep; 36(9):7017-26. PubMed ID: 25861751
[TBL] [Abstract][Full Text] [Related]
3. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis.
Chu D; Li P; Li Y; Shi J; Huang S; Jiao P
Thorac Cancer; 2021 Nov; 12(21):2894-2906. PubMed ID: 34523261
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene.
Sun X; Lou L; Zhong K; Wan L
Exp Biol Med (Maywood); 2017 Jun; 242(12):1299-1305. PubMed ID: 28429654
[TBL] [Abstract][Full Text] [Related]
5. Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1.
Ma J; Wang T; Guo R; Yang X; Yin J; Yu J; Xiang Q; Pan X; Tang H; Lei X
J Drug Target; 2015; 23(6):519-24. PubMed ID: 25714665
[TBL] [Abstract][Full Text] [Related]
6. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
Sekino Y; Sakamoto N; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
[TBL] [Abstract][Full Text] [Related]
7. miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5.
Zhang X; Wang C; Li H; Niu X; Liu X; Pei D; Guo X; Xu X; Li Y
Oncotarget; 2017 Sep; 8(38):64106-64113. PubMed ID: 28969055
[TBL] [Abstract][Full Text] [Related]
8. miR-30c-2-3p suppresses the proliferation of human renal cell carcinoma cells by targeting TOP2A.
Huang X; Jia Y; Shi H; Fan H; Sun L; Zhang H; Wang Y; Chen J; Han J; Wang M; Du J; Zhang J
Asian Biomed (Res Rev News); 2023 Jun; 17(3):124-135. PubMed ID: 37818158
[TBL] [Abstract][Full Text] [Related]
9. miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs.
Chen M; Li D; Gong N; Wu H; Su C; Xie C; Xiang H; Lin C; Li X
Oncotarget; 2017 Aug; 8(32):52983-52994. PubMed ID: 28881788
[TBL] [Abstract][Full Text] [Related]
10. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
[TBL] [Abstract][Full Text] [Related]
11. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Huang C; Ma T; Jiang L; Tang L; Shi T; Zhang S; Zhang L; Zhu P; Li J; Shen A
Phytomedicine; 2018 Apr; 43():37-45. PubMed ID: 29747752
[TBL] [Abstract][Full Text] [Related]
12. miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma.
Huang J; Dong B; Zhang J; Kong W; Chen Y; Xue W; Liu D; Huang Y
Tumour Biol; 2014 Jun; 35(6):5833-43. PubMed ID: 24609899
[TBL] [Abstract][Full Text] [Related]
13. Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells.
Long QZ; Zhou M; Liu XG; Du YF; Fan JH; Li X; He DL
Anticancer Drugs; 2013 Sep; 24(8):810-7. PubMed ID: 23744557
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
15. circTLK1 facilitates the proliferation and metastasis of renal cell carcinoma by regulating miR-495-3p/CBL axis.
Lei X; Yang M; Xiao Z; Zhang H; Tan S
Open Life Sci; 2021; 16(1):362-374. PubMed ID: 33954256
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of connexin 32 gene by 5-aza-2'-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling.
Takano Y; Iwata H; Yano Y; Miyazawa M; Virgona N; Sato H; Ueno K; Yano T
Biochem Pharmacol; 2010 Aug; 80(4):463-70. PubMed ID: 20510207
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1.
Tian P; Wei JX; Li J; Ren JK; Yang JJ
Cell Biol Int; 2021 Jul; 45(7):1546-1560. PubMed ID: 33739543
[TBL] [Abstract][Full Text] [Related]
18. The expression of mdr-1-related gp-170 and its correlation with anthracycline resistance in renal cell carcinoma cell lines and multidrug-resistant sublines.
Yu DS; Chang SY; Ma CP
Br J Urol; 1998 Oct; 82(4):544-7. PubMed ID: 9806185
[TBL] [Abstract][Full Text] [Related]
19. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L
Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-222-3p Reverses Doxorubicin-Resistance in LoVo Cells Through Upregulating Forkhead Box Protein P2 (FOXP2) Protein.
Wang H; Deng Z; Chen X; Cai J; Ma T; Zhong Q; Li R; Li L; Li T
Med Sci Monit; 2019 Mar; 25():2169-2178. PubMed ID: 30904920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
